Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “24-hour Glucose Control”

28 trials

Showing 20 of 28 results

Post-approval studies (Phase 4)Study completedNCT00318656
What this trial is testing

24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes

Who this might be right for
Non-Insulin-Dependent Diabetes Mellitus
GlaxoSmithKline 23
Not applicableStudy completedNCT06319443
What this trial is testing

Daily Vinegar Ingestion and 24-Hour Blood Glucose Control

Who this might be right for
Glucose Intolerance
Arizona State University 10
Not applicableStudy completedNCT03579615
What this trial is testing

Comparison of Day and Night Closed-loop With Faster-acting Insulin Aspart With Insulin Aspart

Who this might be right for
Diabetes Mellitus, Type 1
Manchester University NHS Foundation Trust 18
Testing effectiveness (Phase 2)Study completedNCT01754337
What this trial is testing

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults and Adolescents With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Institut de Recherches Cliniques de Montreal 30
Not applicableUnknownNCT03739099
What this trial is testing

Efficacy of Closed-loop Insulin Therapy in Prepubertal Child in Free-life

Who this might be right for
Type 1 Diabetes Mellitus in Prepubertal Children
University Hospital, Montpellier 122
Not applicableStudy completedNCT05358171
What this trial is testing

Ultra-processed Food Consumption, Gut Microbiota, and Glucose Homeostasis

Who this might be right for
Insulin Sensitivity24-hour Glucose Control
Virginia Polytechnic Institute and State University 20
Post-approval studies (Phase 4)Study completedNCT00367445
What this trial is testing

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 30
Not applicableStudy completedNCT04894344
What this trial is testing

Education to Decrease in Sodium Intake Evaluated With 24 Hour Urinary Sodium Excretion (RCT)

Who this might be right for
HypertensionOverweight or ObesityDiabetes Mellitus, Type 2
Universidad Autonoma de Baja California 196
Post-approval studies (Phase 4)Study completedNCT02288273
What this trial is testing

Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

Who this might be right for
Type 2 Diabetes
AstraZeneca 239
Testing effectiveness (Phase 2)Study completedNCT01508923
What this trial is testing

Effect of Liraglutide on Glucose Profiles and Gastric Emptying in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 17
Early research (Phase 1)Ended earlyNCT01755442
What this trial is testing

Investigate Effect of AMG 151 on 24-hour Ambulatory Blood Pressure & Glucose Levels in Type 2 Diabetes Mellitus Subjects

Who this might be right for
Diabetes Mellitus
Amgen 5
Large-scale testing (Phase 3)Study completedNCT01947855
What this trial is testing

Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 60
Not applicableLooking for participantsNCT03504683
What this trial is testing

MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

Who this might be right for
PreDiabetes
University of Alabama at Birmingham 144
Testing effectiveness (Phase 2)Study completedNCT01242904
What this trial is testing

Use of a Bimodal Solution for Peritoneal Dialysis

Who this might be right for
End Stage Renal Disease
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 36
Early research (Phase 1)Study completedNCT01147861
What this trial is testing

Evaluate the Effect of GSK256073, an HM74A Receptor Agonist, on Glucose and NEFA Levels in Type 2 Diabetics

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 39
Not applicableLooking for participantsNCT06425640
What this trial is testing

24-hour Movement Behaviors in Adults With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
University Hospital, Ghent 150
Early research (Phase 1)Study completedNCT02500979
What this trial is testing

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 34
Early research (Phase 1)Study completedNCT01044017
What this trial is testing

Single Doses of RO4998452 in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 22
Not applicableStudy completedNCT03350997
What this trial is testing

Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control

Who this might be right for
Metabolic DiseaseAdipose Tissue
University of Michigan 22
Post-approval studies (Phase 4)Study completedNCT02429258
What this trial is testing

Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin

Who this might be right for
Type II Diabetes
AstraZeneca 226
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation